HR4019-119

What This Bill Does

Gio's Law creates a Law Enforcement Access to Emergency Epinephrine Grant Program. The Attorney General may award grants to states and local governments to purchase epinephrine products for state, local, and Tribal law enforcement agencies and to train officers using curricula developed or identified by DOJ. Within 180 days, DOJ must develop or identify training that teaches officers to recognize anaphylactic reactions and correctly administer epinephrine products to people reasonably believed to be having one. Applications must include a certification from the state attorney general that officers authorized in that jurisdiction to administer epinephrine are protected from civil liability arising from administration. Epinephrine products include auto-injectors and products that administer epinephrine other than by injection. The bill authorizes $25 million for each fiscal year 2026 through 2030. DOJ, through the Bureau of Justice Statistics, must annually submit to Congress and publicly release data on how often federal, state, local, and Tribal law enforcement officers administer epinephrine products. DOJ and HHS must create a public awareness campaign within 180 days about anaphylaxis symptoms and the role of law enforcement officers and first responders in administering epinephrine.

Who Benefits and How

People experiencing anaphylaxis benefit if officers carry epinephrine and know how to administer it quickly. State law enforcement agencies benefit from grants to purchase epinephrine products and train officers. Local law enforcement agencies benefit from the same purchasing and training support. Tribal law enforcement agencies benefit because grants can buy products for Tribal officers and include them in training. First responders benefit from a public campaign clarifying their role in anaphylaxis emergencies.

Who Bears the Burden and How

Attorney General grant staff must develop or identify training, administer grants, and review applications. State attorneys general must certify officer civil-liability protection for grant applicants. Bureau of Justice Statistics staff must collect, report, and publish annual epinephrine administration data. HHS outreach staff must collaborate with DOJ on a public awareness campaign. Law enforcement officers must complete training before administering epinephrine products under the program.

Key Provisions

• Authorizes DOJ grants to purchase epinephrine products and train law enforcement officers.
• Requires standardized anaphylaxis recognition and epinephrine administration training within 180 days.
• Requires state attorney general certification of civil-liability protection.
• Authorizes $25,000,000 for each fiscal year 2026 through 2030.
• Requires annual public BJS data on law enforcement epinephrine administration.
• Directs DOJ and HHS to implement a public awareness campaign within 180 days.